[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Ammar Jassim Abed\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":48},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":29,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":5},"100619796",false,"NCT07349277","Evaluation of sFlt-1\u002FPlGF Ratio ,OPG and sEng as Predictive Biomarkers in the Diagnosis and Treatment Evaluation of Preeclampsia","Evaluation of sFlt-1\u002FPlGF Ratio, Osteoprotegerin (OPG) and Soluble Endoglin (sEng) as Predictive Biomarkers in the Diagnosis and Treatment Evaluation of Preeclampsia","PE-POSS","IInclusion Criteria:\n\n* Pregnant women between 20 and 36 weeks of gestation\n* Age between 18 and 45 years\n* Attending the antenatal clinic at the study site\n\nExclusion Criteria:\n\n* Chronic hypertension\n* Renal disease\n* Diabetes mellitus\n* Multiple gestations\n* Autoimmune disorders",true,"FEMALE","18 Years","45 Years",{"count":21,"type":22},120,"ESTIMATED","OBSERVATIONAL","his study investigates the effectiveness of three specific biological markers (biomarkers) in the blood-the sFlt-1\u002FPlGF ratio, soluble endoglin (sEng), and osteoprotegerin (OPG)-to better diagnose and monitor preeclampsia. Preeclampsia is a serious pregnancy complication characterized by high blood pressure and potential organ damage that affects 2-8% of pregnancies worldwide",[26,27,28],"Preeclampsia","Gestational Hypertension","Hypertensive Disorders of Pregnancy",[30,31,32,33,34,26,35],"sFlt-1\u002FPlGF ratio","Soluble Endoglin (sEng)","Osteoprotegerin (OPG)","Angiogenesis","Placental Dysfunction","methyldopa","RECRUITING","2026-01-15",{"date":39,"type":40},"2026-01-20","ACTUAL",{"date":42,"type":40},"2025-10-10",{"date":44,"type":22},"2026-04-30",{"name":46,"class":47},"Ammar Jassim Abed","OTHER",""]